Riikka H.
- Country
- Finland
- Department
- Oncology
Research Overview
Data & Insights
Has run more than one trial at 0 of 6 partner sites.
Specializations
Breast Cancer Specialization
This investigator focuses on advanced therapeutic approaches in early-stage breast cancer treatment, with particular emphasis on targeted therapies for different molecular subtypes.
- HER2-positive breast cancer interventions
- Estrogen receptor-positive breast cancer management
- Novel adjuvant therapy approaches
The investigator's work encompasses both hormone receptor-positive and HER2-positive disease subtypes, exploring innovative therapeutic combinations.
Targeted Therapeutics
The investigator specializes in evaluating novel targeted treatments, including anti-HER2 therapies and endocrine therapy approaches for breast cancer.
- Targeted molecular therapies
- Combination treatment strategies
- Endocrine therapy optimization
Their research encompasses evaluation of emerging therapeutic agents and their integration into established treatment protocols.
Clinical Outcomes Research
The investigator's work centers on assessing therapeutic efficacy through key clinical endpoints, particularly invasive disease-free survival in early breast cancer.
- Treatment response assessment
- Long-term outcome evaluation
- Comparative effectiveness research
Their research focuses on determining optimal treatment strategies for improved patient outcomes in early-stage breast cancer.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.